News

Novo Nordisk ( NVO 0.33%) stock jumped 3.1% at the open Thursday morning before drifting back. As of 10:54 a.m. ET, it was ...
Eli Lilly has enjoyed a successful run the past several quarters as the company's blockbuster GLP-1 weight-loss drug Wegovy ...
Wegovy was first to market but has been losing ground to Eli Lilly's Zepbound in recent months, according to the latest ...
The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...
Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...
The WHO's conditional recommendation will be officially released in August, as part of new guidelines on treating obesity. It ...
The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...
Amazon talks up AI potential on earnings call, points to limited tariff impact. American Airlines commits to $4 billion ...
Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health's decision to drop the company's obesity ...
CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health ...